VIVIMEDLAB

VIVIMED LABS

Small Cap BSE: 532660 NSE: VIVIMEDLAB
₹11.25
0.5 (4.65%)
As on 06 December, 2022 | 12:58

Vivimed Labs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in VIVIMED LABS

Start SIP

Vivimed Labs Share Price

Vivimed Labs Share Returns

  • Over 1 Month 19.05%
  • Over 3 Month 17.19%
  • Over 6 Month -15.73%
  • Over 1 Year -37.33%

Vivimed Labs Key Statistics

P/E Ratio -1.1
PEG Ratio -0.1
Market Cap Cr 93
Price to Book Ratio 0.3
EPS -8.2
Dividend 0
Relative Strength Index 70.85
Money Flow Index 54.34
MACD Signal -0.07
Average True Range 0.37

Vivimed Labs Investment Rating

  • Master Rating:
  • Vivimed Labs has an operating revenue of Rs. 211.98 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of -27% needs improvement, ROE of -18% is poor and needs improvement. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 11% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 16 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivimed Labs Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 39475352516235
Operating Expenses Qtr Cr 49565559625155
Operating Profit Qtr Cr -10-9-2-7-1111-20
Depreciation Qtr Cr 4454444
Interest Qtr Cr 991012999
Tax Qtr Cr 0030000
Net Profit Qtr Cr -22-22-19-24-23-2-31

Vivimed Labs Technicals

EMA & SMA

Current Price
11.25
0.5 (4.65%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 9.55
  • 50 Day
  • 9.68
  • 100 Day
  • 10.39
  • 200 Day
  • 12.35
  • 20 Day
  • 9.48
  • 50 Day
  • 9.65
  • 100 Day
  • 9.98
  • 200 Day
  • 12.34

Vivimed Labs Resistance and Support

PIVOT
₹10.6
Resistance
First Resistance 10.9
Second Resistance 11.05
Third Resistance 11.35
RSI 70.85
MFI 54.34
MACD Single Line -0.07
MACD 0.1
Support
First Resistance 10.45
Second Resistance 10.15
Third Resistance 10

Vivimed Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 249,404 24,940,400 100
Week 239,373 22,127,622 92.44
1 Month 150,530 12,104,113 80.41
6 Month 232,432 15,059,300 64.79

Vivimed Labs Result Highlights

Vivimed Labs Synopsis

NSE-Medical-Diversified

Vivimed Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 210.05 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2021. Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465.
Market Cap 93
Sales 192
Shares in Float 6.55
No of funds 4
Yield
Book Value 0.19
U/D Vol ratio 0.7
LTDebt / Equity 13
Alpha -0.2
Beta 1.11

Vivimed Labs

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 20.96%20.96%21.98%
Foreign Portfolio Investors 1.64%1.64%1.64%
Individual Investors 57.64%57.38%53.46%
Others 19.76%20.02%22.92%

Vivimed Labs Management

Name Designation
Prof. Bhagvanth Rao Mamidpalli Chairman & Ind.Director
Mr. Santosh Varalwar Managing Director
Dr. Manohar Rao Varalwar Whole Time Director
Mr. Sandeep Varalwar Whole Time Director
Mr. Subhash Varalwar Non Executive Director
Mrs. Umanath Varahabhotla Independent Director
Dr. Jamalapuram Harigopal Independent Director

Vivimed Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivimed Labs Corporate Action

Date Purpose Remarks
2022-08-12 Quarterly Results
2022-06-03 Audited Results (Revised) per share(20%)Dividend
2022-02-14 Quarterly Results
2021-11-13 Quarterly Results
2021-09-06 Preferential issue of shares

Vivimed Labs FAQs

What is Share Price of Vivimed Labs ?

Vivimed Labs share price is ₹11 As on 06 December, 2022 | 12:44

What is the Market Cap of Vivimed Labs ?

The Market Cap of Vivimed Labs is ₹93.3 Cr As on 06 December, 2022 | 12:44

What is the P/E ratio of Vivimed Labs ?

The P/E ratio of Vivimed Labs is -1.1 As on 06 December, 2022 | 12:44

What is the PB ratio of Vivimed Labs ?

The PB ratio of Vivimed Labs is 0.3 As on 06 December, 2022 | 12:44

Q2FY23